Growth inhibition of human cervical cancer cells with the recombinant adenovirus p53 in vitro

Gynecologic Oncology

Volumn 60, Issue 3, 1996, Pages 373-379

  Hamada, Katsuyuki ^a,b   Zhang, Wei Wei ^a   Alemany, Ramon ^a   Wolf, Judith ^a   Roth, Jack A ^a   Mitchell, Michele Follen ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Box 109 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROTEIN P53; VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CYTOMEGALOVIRUS; FEMALE; FEMALE GENITAL TRACT INFECTION; GENE THERAPY; GENETIC TRANSDUCTION; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS INFECTION; VIRUS RECOMBINANT; WART VIRUS;

EID: 0029993623     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0057     Document Type: Article

References (31)

1. Brinton, L. A. The epidemiology of human papillomavirus and cervical cancer, in Epidemiology of cervical cancer - Overview (N. Munoz, F. Bosch, K. V. Shah, and A. Meheus, Eds.), Lyon, Vol. 119, pp. 3-23 (1992).
2. zur Hausen, H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancer, Cancer Res. 49, 4677-4681 (1989).
3. Galloway, D. A., and McDougall, J. K. Human papillomaviruses and carcinoma, Adv. Virus Res. 37, 125-171 (1989).
4. Durst, M., Gissmann, L., Ikenberg, H., et al. A papillomavirus DNA from a cervical carcinomas and its prevalence in cancer biopsy samples from different geographic regions, Proc. Natl. Acad. Sci. USA 80, 3812-3815 (1983).
5. Wettstein, F. O. Papillomaviruses and human cancer, in State of viral DNA and gene expression in benign vs. malignant tumors (H. Pfister, Ed), CRC Press, Boca Raton, FL, p. 145 (1990).
6. Seedorf, K., Krammer, G., Durst, M., et al. Identification of early proteins of the papillomaviruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells, EMBO J. 6, 139-144 (1987).
7. Kaur, P., McDougall, J. K., and Cone, R. Immortalization of primary human epithelial cells by cloned cervical carcinoma DNA containing human papillomavirus type 16 E6/E7 opening reading frames, J. Gen. Virol. 70, 1261-1266 (1989).
8. Münger, K., Phelps, W. C., Bubb, V., et al. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes, J. Virol. 63, 4417-4421 (1989).
9. Heck, D. V., Yee, C. L., Howley, P. M., et al. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses, Proc. Natl. Acad. Sci. USA 89, 4442-4446 (1992).
10. Kessis, T. D., Slebos, R. J., Nelson, W. G., et al. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage, Proc. Natl. Acad. Sci. USA 90, 2988-2992 (1993).
11. Crook, T., and Vousden, K. H. Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environment carcinogens, EMBO J. 11, 3935-3940 (1992).
12. Scheffner, M., Takahashi, T., Huibregtse, J. M., et al. Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins, J. Virol. 66, 5100-5105 (1992).
13. Howley, P. M., Scheffner, M., and Munger, K. Oncoproteins encoded by the cancer-associated human papillomavirus target the products of the retinoblastoma and p53 tumor suppressor genes, Cold Spring Harbor Symp. 56, 149-155 (1991).
14. Zhang, W. W., Fang, X., Mazur, W., French, B. A., Georges, R. N., and Roth, J. A. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus, Cancer Gene Ther. 1, 4-15 (1994).
15. Liu, T. J., Zhang, W. W., Taylor, D. L., et al. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus, Cancer Res. 54, 3662-3667 (1994).
16. Fujiwara, T., Grimm, E. A., Mukhopadhyay, T., et al. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene, Cancer Res. 54, 2287-2291 (1994).
17. Chen, T. M., Chen, C. A., Hsieh, C. Y., et al. The state of p53 in primary human cervical carcinomas and its effects in human papillomavirus-immortalized human cervical cells, Oncogene 8, 1511-1518 (1993).
18. Yee, C., Krishnan-Hewlett, I., Baker, C. C., et al. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines, Am. J. Pathol. 119, 361-366 (1985).
19. Scheffner, M., Münger, K., Byrne, J. C., and Howley, P. M. The state of the p53 and retinoblastoma genes in human cerivcal carcinoma cell lines, Proc. Natl. Acad. Sci. USA 88, 5523-5527 (1991).
20. Diller, L., Kassel, J., Nelson, C. E., et al. p53 functions as a cell cycle control protein in osteosarcomas, Mol. Cell. Biol. 10, 5772-5781 (1990).
21. Fujiwara, T., Grimm, E. A., Mukhopadhyay, T., et al. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis, Cancer Res. 53, 4129-4133 (1993).
22. El-Deiry, W. S., Harper, J. W., O'Connor, P. M., et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis, Cancer Res. 54, 1159-1174 (1994).
23. Couch, R. B., Chanock, R. M., Cate, T. R., et al. Immunization with types 4 and 7 adenovirus by selective infection of the intestinal tract, Am. Rev. Respir. Dis. 88, 394-403 (1963).
24. Rosenfeld, M. A., Siegfried, W., and Yoshimura, K. Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis, Hum. Gene Ther. 252, 431-434 (1991).
25. Ragot, T., Vincent, N., Chafey, P., et al. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice, Nature 361, 647-650 (1993).
26. Herz, J., and Gerald, R. D. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice, Proc. Natl. Acad. Sci. USA 90, 2812-2816 (1993).
27. Le Gal La Salle, G., Robert, J. J., Bernard, S., et al. An adenovirus vector for gene transfer into neurons and glia in the brain, Science 259, 988-990 (1993).
28. Jaffe, H. A., Danel, C., Longenecker, G., et al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver, Nat. Genet. 1, 372-378 (1992).
29. Engelhardt, J. F., Simon, R., Yang, Y., et al. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Biological efficacy study, Hum. Gene Ther. 4, 759-769 (1993).
30. Dai, Y., Schwarz, E. M., Gu, D., Zhang, W. W., Sarvetnick, N., and Verma, I. M. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression, Proc. Natl. Acad. Sci. USA 92, 1401-1405 (1995).
31. Engelhardt, J. F., Xuehai, Y., Doranz, B., and Wilson, J. M. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver, Proc. Natl. Acad. Sci. USA 91, 6196-6200 (1994).